3623 results for «657»
3623 results
Major Late-Breaking Trials from EuroPCR 2025
21 May 2025 – From EuroPCR 2025
Discover major late-breaking trials from EuroPCR 2025 in this session presenting pivotal study data. Highlights include meta-analyses from the PROTECTED TAVR and BHF PROTECT-TAVI studies, angiography versus physiology-guided PCI during TAVI (FAITAVI trial), and novel antiplatelet strategies following drug-coated stent implantation in acute coronary syndrome, with...
Treatment dilemmas in STEMI patients with multivessel disease
21 May 2025 – From EuroPCR 2025
Address treatment dilemmas in STEMI patients with multivessel disease through this session focused on imaging and physiology-guided revascularisation strategies. Learn optimal approaches for cases with CABG indications, and timing considerations for non-culprit vessel revascularisation during hospital admission or later stages, supported by illustrative clinical cases.
Stent technologies, last evidence in coronary interventions
21 May 2025 – From EuroPCR 2025
Update your knowledge on the latest stent technologies and clinical evidence in coronary interventions. This session reviews long-term outcomes of resorbable magnesium scaffolds, seven-year data from the COMPARE-ABSORB trial, bioadaptor versus stent comparisons, dual therapy sirolimus-eluting versus biolimus-eluting stents, and randomized trials on direct stenting versus...
Case-based learning on different aspects of transcatheter LAA closure
21 May 2025 – From EuroPCR 2025
Engage in case-based learning focused on transcatheter left atrial appendage (LAA) closure. This session covers safe transseptal puncture techniques, state-of-the-art standard LAA closure procedures, management of challenging LAA anatomies, and optimization of post-procedure antithrombotic therapy in high-risk patients.
Choices, choices: a global perspective on multiple modalities for calcium modification
21 May 2025 – From EuroPCR 2025
Gain a global perspective on multiple modalities for calcium modification in coronary interventions. This session reviews comparative analyses of orbital, shockwave, rotational atherectomy, and cutting balloons, explores evolving rotational atherectomy practices in the era of intravascular lithotripsy, and presents preliminary data from international registries on coronary...
Interventional approaches for cardiogenic shock
21 May 2025 – From EuroPCR 2025
Gain comprehensive insights into interventional strategies for cardiogenic shock, including management of non-ischemic etiologies, innovative use of ventricular vents with ECMO, the interplay of Impella, PCI, and MitraClip, and bridging techniques using left atrial veno-arterial ECMO in severe valve disease and biventricular failure.
Updates in transcatheter MVR
21 May 2025 – From EuroPCR 2025
This session provides a detailed overview of recent advances in transcatheter mitral valve replacement (TMVR). Examine outcomes from next-generation transcatheter heart valves, long-term clinical data from mitral valve-in-valve and valve-in-ring procedures, and explore innovative approaches including transseptal MVR with insights from global studies.
Paravalvular leak closure: challenges and percutaneous solutions
21 May 2025 – From EuroPCR 2025
This session addresses the challenges and percutaneous techniques for paravalvular leak closure following valve replacement. Through complex case studies, it explores managing unexpected anatomical defects, dealing with failed closure attempts, and strategies in malpositioned valves, providing practical guidance for successful intervention in difficult scenarios.
Cathlab harmony: building high-performance teams
21 May 2025 – From EuroPCR 2025
Discover strategies to build and maintain high-performance teams in the cathlab environment. This session outlines how to foster a collaborative culture, address toxic behaviors, and effectively train and integrate team members to enhance teamwork and procedural success in cardiovascular interventions.
Imaging-guided management of PCI pitfalls in NSTEMI
21 May 2025 – From EuroPCR 2025
Dive into the imaging-guided management of PCI pitfalls in NSTEMI patients. This session highlights critical cases such as complications from missed PCI, crushed stents, multiple coronary lumens, and migrating thrombus, emphasizing the role of advanced intracoronary imaging for precise diagnosis and optimized interventional outcomes.
DES and bioadaptator technologies in contemporary practice
21 May 2025 – From EuroPCR 2025
Delve into contemporary practice with this session on drug-eluting stents (DES) and bioadaptator technologies. Gain insights from international studies on complex PCI outcomes, comparative data from randomized trials, and real-world experiences focusing on high bleeding risk patients and elderly cohorts treated with ultrathin strut and new-generation...
CTO, modern challenges and solutions
21 May 2025 – From EuroPCR 2025
Address modern challenges in chronic total occlusion (CTO) interventions with this session focusing on the latest technologies and techniques. Learn key procedural strategies and best practices through detailed case studies, and understand how evolving technology is shaping the future of CTO revascularization.
New evidence in the PFO closure
21 May 2025 – From EuroPCR 2025
Gain new insights into patent foramen ovale (PFO) closure with this session exploring age-related outcomes, risk of atrial arrhythmia, and patient selection improvements. Review various imaging approaches for assessing residual shunts and compare guidance techniques including TEE, fluoroscopy, and intracardiac echo from recent clinical registries.
Metalfree PCI
21 May 2025 – From EuroPCR 2025
Explore metal-free PCI approaches emphasizing drug-coated balloon angioplasty and bioresorbable scaffold technologies. This session reviews angiographic outcomes in diffuse small vessel disease, bifurcation lesions, and acute myocardial infarction, alongside management strategies for restenosis post-DCB angioplasty, highlighting advancements in minimally invasive coronary interventions.
More on long-term responsiveness and effectiveness of renal denervation
21 May 2025 – From EuroPCR 2025
This session presents comprehensive data on the long-term responsiveness and effectiveness of renal denervation. Topics include outcomes in patients with chronic kidney disease, arterial stiffness correlations, safety profiles over nine years, and economic evaluations across European healthcare systems.
Overcoming resistant lesions in NSTEMI
21 May 2025 – From EuroPCR 2025
Address the challenges of resistant lesions in NSTEMI with this focused session. Learn from complex cases involving thrombus management using Penumbra systems and Guideliner, as well as strategies to overcome extensive calcification through multiple interventional tools, illustrating a stepwise approach to tackling difficult coronary lesions.
LAA closure and anthrombotic therapies
21 May 2025 – From EuroPCR 2025
Explore contemporary evidence on left atrial appendage (LAA) closure and associated antithrombotic therapies. This session covers strategies for antithrombotic de-escalation, efficacy and safety in patients with anticoagulation contraindications, breakthrough stroke etiology, and anatomical considerations in high-risk atrial fibrillation patients undergoing ablation.
Coronary scaffolds: new developments and applications
21 May 2025 – From EuroPCR 2025
Stay informed on advancements in coronary scaffolds with this session reviewing new developments and applications. Topics include comparative performance of magnesium-based bioresorbable stents, long-term clinical outcomes from the BIOMAG-I and FANTOM BRS studies, and real-world experiences with next-generation thin-strut scaffolds.
TAV-in-TAV in SAV 3 valves procedures
21 May 2025 – From EuroPCR 2025
Examine the complexities of TAV-in-TAV procedures in degenerated surgical aortic valves (SAV) and TAVI valves. This session discusses cases involving massive aortic regurgitation, lifetime management challenges, and valve-in-valve-in-valve scenarios, providing practical insights into managing multiple valve interventions and associated complications.
Mitral TEER in challenging scenarios - Part 2
21 May 2025 – From EuroPCR 2025
This session focuses on challenging scenarios encountered during mitral transcatheter edge-to-edge repair (TEER). Learn about management of complications such as haemolysis, device malfunctions, and complex vascular access issues, supported by instructive case presentations including bailout strategies in cardiogenic shock and infective endocarditis.
